GLP-1 News Basket

Thesis

Trade GLP-1 business news through tokenized drugmakers, a manufacturing partner and an injection-component maker.

Strategy

• News trades: GLP-1 alerts buy related LLYx, NVOx, TMOx or WSTx; adverse headline or summary keywords sell those holdings for USDC. • Supply-chain coverage: Ingredient news uses LLYx, NVOx and TMOx as indirect exposures; manufacturing and device news use TMOx and WSTx. • Equal position slots: Split available USDC across unfilled slots in the four-stock basket, hold one position per stock and reopen after news-driven sales.

Exposure

• Holds: Four stock tokens — LLYx, NVOx, TMOx and WSTx track Eli Lilly, Novo Nordisk, Thermo Fisher and West Pharmaceutical; unfilled slots remain in USDC. • Venue: Arbitrum swaps — Tokens sit in your wallet; hold ETH for gas and meet xStocks eligibility rules, which exclude U.S. persons. • Leverage: None — Buys stock tokens without borrowing. • Costs: Swaps and gas — Pays swap spreads, routing fees and Arbitrum gas. • Data: Circuit — Uses news alerts, asset identities and allocation; headline-word rules set direction, with no outside service called during runs. • On unwind: Tokens stay in wallet — Stopping leaves USDC and unsold stock tokens in your wallet; it does not automatically sell tokens.